ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2727

Prevalence of Clinical and Subclinical Ophthalmologic Manifestations in Association with Systemic Symptoms, Disease Activity and Damage in Patients with Granulomatosis with Polyangiitis

Andrea Hinojosa-Azaola1, Annette García-Castro2 and Alejandra Juárez-Flores3, 1Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, 2Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 3Ophthalmology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ANCA, ocular involvement and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Vasculitis – ANCA-Associated Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Ophthalmologic involvement in Granulomatosis with Polyangiitis (GPA) is present in 50-60% of the patients and can affect any part of the ocular glove and the orbit. We aimed to describe clinical and subclinical ophthalmologic manifestations, association with systemic symptoms, disease activity and damage in patients with GPA.

Methods: Cross-sectional study including patients with GPA diagnosis (ACR 1990 classification criteria and/or 2012 Chapel Hill Consensus definitions). All patients underwent rheumatologic and ophthalmologic evaluation. Information regarding demographics, comorbidities, clinical variables, ophthalmologic symptoms, serologic markers, radiographic studies, disease activity and damage was retrieved. Descriptive statistics, correlation and univariable logistic regression analyses, Student t, Mann-Whitney U, chi square and Fisher’s exact tests were performed.

Results: Fifty patients were included, 60% female, age 56 years (24-82), disease duration 72.5 months (0-469). Nineteen patients (38%) had ophthalmic manifestations at GPA diagnosis; being sleritis/episcleritis the most frequent (18%), while 27 (54%) presented them during follow-up, with repeated scleritis/episcleritis and lacrimal gland involvement being the most frequent. Concomitant ophthalmic and sinusal involvement was present in 12 (24%). Radiologic abnormalities were observed in 35 (76%), being sinusitis the most frequent (Table 1). BVAS/GPA was 1 (0-17) and VDI 5.5 (0-11), with ocular and ENT damage being present in 58% and 70%, respectively. Forty three patients (86%) presented at least one ophthalmologic symptom, being epiphora and blurred vision the most frequent (40%). At least one clinical abnormality was found in 31 (62%). Scleromalacia (27%) and conjunctival hyperemia (26%) were the most frequent findings (Table 2). Association between radiographic granulomas and clinical proptosis (r=0.69, p=0.001), and between extraconal fat herniation and episcleritis (r=0.69, p=0.0001) was found. Ophthalmic involvement at diagnosis was associated with concomitant ophthalmic and sinusal involvement at follow-up (OR 4.72, 95% CI 1.17-19.01, p=0.01). Ophthalmic involvement at follow-up was associated with age at GPA diagnosis (OR 0.94, 95% CI 0.90-0.99, p=0.03), VDI (OR 1.29, 95% CI 1.03-1.61, p=0.02), and ENT damage (OR 5.27, 95% CI 1.37-20.13, p=0.01).

Conclusion: In GPA, clinical and subclinical ophthalmic involvement is frequent at diagnosis and follow-up, it is associated with concomitant sinusal involvement and has impact on ocular and ENT damage.

Table 1.

Variable

n (%)

Ophthalmic manifestations at diagnosis

Scleritis/Episcleritis

Lacrimal gland involvement

Optic nerve involvement

Retinal artery occlusion

Ulcerative keratitis

Uveitis

Pseudotumor

19 (38)

9 (18)

2 (4)

3 (6)

2 (4)

3 (6)

2 (4)

1 (2)

Ophthalmic manifestations at follow-up

Scleritis/Episcleritis

Repeated scleritis/episcleritis

Lacrimal gland involvement

Chronic dacryocystitis

Retinal involvement

Uveitis

Optic nerve involvement

Other

27 (54)

6 (12)

8 (16)

8 (16)

4 (8)

2 (4)

3 (6)

4 (8)

7 (14)

Concomitant ophthalmic and sinusal involvement

12 (24)

Radiologic findings (n=46)

Radiologic abnormalities

Sinusitis

Granulomas

Pseudotumor

Bone erosions

Pachymeningitis

Mastoiditis

Otomastoiditis

Lateral cartilage collapse

Septal perforation

Exophthalmos

Lacrimal gland enlargement

Extraconal fat herniation

n (%)

35 (76)

25 (54)

4 (9)

2 (4)

10 (22)

2 (4)

5 (11)

4 (9)

17 (37)

19 (41)

7 (15)

6 (13)

2 (4)

Table 2.

Sign

Either eye n (%)

Blindness

12 (24)

Extraocular muscular involvement

2 (4)

Exophthalmos

10 (20)

Orbital granuloma

2 (4)

Palpebral edema/inflammation

3 (6)

Proptosis

2 (4)

Ptosis

3 (6)

Dacryocystitis

9 (18)

Nasal conjunctive fistulas

2 (4)

Optic neuropathy

3 (6)

Diplopia

1 (2)

Epiphora

10 (20)

Conjunctival inflammation/hyperemia

13 (26)

Episcleritis

1 (2)

Necrotizing scleritis

1 (2)

Ulcerative peripheral keratitis

2 (4)

Keratoconjunctivitis sicca

4 (8)

Scleromalacia

13 (27)

Retinal vasculitis

1 (2)

Retinal exudates

1 (2)


Disclosure: A. Hinojosa-Azaola, None; A. García-Castro, None; A. Juárez-Flores, None.

To cite this abstract in AMA style:

Hinojosa-Azaola A, García-Castro A, Juárez-Flores A. Prevalence of Clinical and Subclinical Ophthalmologic Manifestations in Association with Systemic Symptoms, Disease Activity and Damage in Patients with Granulomatosis with Polyangiitis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/prevalence-of-clinical-and-subclinical-ophthalmologic-manifestations-in-association-with-systemic-symptoms-disease-activity-and-damage-in-patients-with-granulomatosis-with-polyangiitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-clinical-and-subclinical-ophthalmologic-manifestations-in-association-with-systemic-symptoms-disease-activity-and-damage-in-patients-with-granulomatosis-with-polyangiitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology